Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients

Clinical trial NCT07036172 · RECRUITING

Trial details

NCT number: NCT07036172
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Control

Start date: 2025-01-03
Primary completion: 2026-04-01
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.